Martin A. Mattingly

Insider Reports History

Entity
Individual
Location
C/O Trimeris, Inc., 2530 Meridian Parkway, 2 Nd Floor, Durham, NC
Signature
/s/ Scott B. Brown, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin A. Mattingly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tracon Pharmaceuticals, Inc. Director Director Stock Option (Right to Buy) 18K Apr 19, 2023 Direct
ACHIEVE LIFE SCIENCES, INC. Director Stock Option (right to buy) 4.4K May 31, 2022 Direct

Insider Reports Filed by Martin A. Mattingly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCON Tracon Pharmaceuticals, Inc. Apr 19, 2023 1 $0 4 Apr 21, 2023 Director
TCON Tracon Pharmaceuticals, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
ACHV ACHIEVE LIFE SCIENCES, INC. May 31, 2022 1 $0 4 Jun 1, 2022 Director
TCON Tracon Pharmaceuticals, Inc. Jun 10, 2021 1 $0 4 Jun 24, 2021 Director
ACHV ACHIEVE LIFE SCIENCES, INC. May 11, 2021 1 $0 4 May 13, 2021 Director